Format

Send to:

Choose Destination
See comment in PubMed Commons below
Curr Pharm Des. 2013;19(11):1966-73.

Advances in clinical study of curcumin.

Author information

  • 1Department of Pharmaceutics, College of Pharmacy, Shandong University, Jinan 250012, China.

Abstract

Curcumin has been estimated as a potential agent for many diseases and attracted great attention owing to its various pharmacological activities, including anti-cancer, and anti-inflammatory. Now curcumin is being applied to a number of patients with breast cancer, rheumatoid arthritis, Alzheimer's disease, colorectal cancer, psoriatic, etc. Several clinical trials have stated that curcumin is safe enough and effective. The objective of this article was to summarize the clinical studies of curcumin, and give a reference for future studies.

PMID:
23116307
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Bentham Science Publishers Ltd.
    Loading ...
    Write to the Help Desk